TAIEquity · Weekly research terminal

6446

PharmaEssentia Corporation

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
7 Aug 2026
Weekly close
1240.00 TWD
Fair value
473.30 TWD
Next-week expectancy
Undecided 49.49%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

6446

PharmaEssentia Corporation

Healthcare Drug Manufacturers - Specialty & Generic

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
619,672,371,200
Fair value reference
473.30
Next-week expectancy
Undecided · 49.49%

Over the latest 12 completed weeks ending 2026-08-07, 6446 rose 70.00%, moving from 729.42 to 1,240.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.73 and has improved across the 12-week window. Market Dynamics is 0.95 on the latest week. Next-week expectancy is undecided at 49.49% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
1,240.00
12-Week Change
70.00%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.49%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
1,240.00
12-Week Change
70.00%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.49%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
51.73
Market Dynamics
0.95

Over the latest 12 completed weeks ending 2026-08-07, 6446 rose 70.00%, moving from 729.42 to 1,240.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 51.73 and has improved across the 12-week window. Market Dynamics is 0.95 on the latest week. Next-week expectancy is undecided at 49.49% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
4119 SCI Pharmtech, Inc. TAI 7 Aug 2026 47.20 51.60 47.00 51.60 9.32%
6472 Bora Pharmaceuticals Co., Ltd. TAI 7 Aug 2026 383.00 430.00 382.50 417.50 9.01%
1795 Lotus Pharmaceutical Co., Ltd. TAI 7 Aug 2026 175.00 192.00 174.50 188.00 7.43%
4746 Formosa Laboratories, Inc. TAI 7 Aug 2026 50.70 54.90 50.50 54.00 6.51%
3054 LIWANLI Innovation Co., Ltd. TAI 7 Aug 2026 48.00 50.90 47.20 50.20 4.58%
1731 MAYWUFA CO TAI 7 Aug 2026 20.65 21.75 20.40 21.10 2.18%
1760 Panion & Bf Biotech Inc. TAI 7 Aug 2026 58.50 60.20 58.10 59.10 1.03%
1720 Standard Chemical & Pharmaceutical Co., Ltd. TAI 7 Aug 2026 56.80 57.30 55.80 57.00 0.35%
3705 YungShin Global Holding Corporation TAI 7 Aug 2026 53.60 53.80 52.80 53.50 -0.19%
1707 Grape King Bio Ltd TAI 7 Aug 2026 89.50 90.60 88.20 89.20 -0.34%
4108 PhytoHealth Corporation TAI 7 Aug 2026 11.20 11.45 11.00 11.15 -0.45%
1789 ScinoPharm Taiwan, Ltd. TAI 7 Aug 2026 19.25 19.50 18.30 18.90 -1.82%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context